Table 3. Adverse Events.
Adverse event | No. (%) | |
---|---|---|
Gram stain–guided group (n = 103) | Guideline-based group (n = 103) | |
Kidney impairment | 17 (16.5) | 19 (18.4) |
Thrombocytopenia | ||
Moderate | 12 (11.7) | 4 (3.9) |
Severe | 4 (3.9) | 7 (6.8) |
Diarrhea | 27 (26.2) | 38 (36.9) |
Clostridioides difficile infection | 1 (1.0) | 3 (2.9) |
Skin rash | 3 (2.9) | 3 (2.9) |
Seizure | 5 (4.9) | 5 (4.9) |